INDEGENE
|
The Current P/B Ratio of INDEGENE is 5.01.
Share Price | ₹546.0 | May 08,2025 |
Market Cap | ₹13,102.8 Cr | |
Book Value | ₹2,615.6 Cr | Mar2025 - Consolidated Results |
Price/Book | 5.01x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of INDEGENE
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹13,102.8 Cr] as on May 08,2025
(/) Book Value [ ₹2,615.6 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 5.01x ]
Thus, for INDEGENE , the investors are currently willing to pay '5.01 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of INDEGENE !
The chart below summarizes the trend in P/B Ratio of INDEGENE over the last five years.
Historical PB (Price/Book ) ratio chart of INDEGENE
PB Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- INDEGENE 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/b ratio peaked in Mar2024 at 0x.
- INDEGENE 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
INDEGENE | 2,615.60 | 5.01 | 13,102.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.66 | 423,771.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.66 | 158,175.0 |
CIPLA LTD | 26,619.90 | 4.51 | 120,076.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.71 | 107,727.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.41 | 95,853.9 |
MANKIND PHARMA LTD | 9,339.84 | 10.75 | 100,426.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.42 | 87,728.5 |
LUPIN LTD | 14,175.80 | 6.49 | 91,953.4 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.25 | 67,274.2 |
ABBOTT INDIA LTD | 3,658.73 | 17.44 | 63,795.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs INDEGENE 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.25x |
Max industry PB | 17.44x |
Median industry PB | 6.49x |
Average industry PB | 8.03x |
You may also like the below Video Courses